Vaccinia virus: a tool for research and vaccine development (Q37755852)

22 August 2017

1 reference

title

Vaccinia virus: a tool for research and vaccine development (English)

1 reference

22 August 2017

1 reference

0 references

Vaccinia virus

1 reference

Moss B

1

1 reference

PubMed ID

2047875

22 August 2017

language of work or name

English

0 references

publication date

1 June 1991

1 reference

22 August 2017

6

1 reference

based on heuristic

inferred from page(s)

published in

Science

1 reference

22 August 2017

252

1 reference

22 August 2017

5013

1 reference

22 August 2017

1662-1667

1 reference

The roles of influenza virus haemagglutinin and nucleoprotein in protection: analysis using vaccinia virus recombinants

22 August 2017

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

The Origins of Vaccinia Virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Recombinant vaccinia virus primes and stimulates influenza haemagglutinin-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Effective tumor immunotherapy directed against an oncogene-encoded product using a vaccinia virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Oral vaccination of the fox against rabies using a live recombinant vaccinia virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

A dominant selectable marker for the construction of recombinant poxviruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Prevention of HIV-1 glycoprotein transport by soluble CD4 retained in the endoplasmic reticulum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Vaccinia virus expression vector: coexpression of beta-galactosidase provides visual screening of recombinant virus plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Insertional inactivation of the large subunit of ribonucleotide reductase encoded by vaccinia virus is associated with reduced virulence in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Eukaryotic transient expression system dependent on transcription factors and regulatory DNA sequences of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Safety of and immunological response to a recombinant vaccinia virus vaccine expressing HIV envelope glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Temporal regulation of influenza hemagglutinin expression in vaccinia virus recombinants and effects on the immune response

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Reciprocity in the interactions between the poxviruses and their host cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

New vaccinia virus recombination plasmids incorporating a synthetic late promoter for high level expression of foreign proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Regulated expression of foreign genes in mammalian cells under the control of coliphage T3 RNA polymerase and lac repressor

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

T-lymphocyte priming and protection against Friend leukemia by vaccinia-retrovirus env gene recombinant

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Cap-independent translation of mRNA conferred by encephalomyocarditis virus 5' sequence improves the performance of the vaccinia virus/bacteriophage T7 hybrid expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Cytoplasmic expression system based on constitutive synthesis of bacteriophage T7 RNA polymerase in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Successful oral rabies vaccination of raccoons with raccoon poxvirus recombinants expressing rabies virus glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Recombinant vaccinia virus vaccine against the human melanoma antigen p97 for use in immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Prevention of vaccinia virus infection in immunodeficient mice by vector-directed IL-2 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Attenuation and immunogenicity in primates of vaccinia virus recombinants expressing human interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Neomycin resistance as a dominant selectable marker for selection and isolation of vaccinia virus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Structure and stability of mRNA synthesized by vaccinia virus-encoded bacteriophage T7 RNA polymerase in mammalian cells. Importance of the 5' untranslated leader

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Use of a hybrid vaccinia virus-T7 RNA polymerase system for expression of target genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Eukaryotic transient-expression system based on recombinant vaccinia virus that synthesizes bacteriophage T7 RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

The complete DNA sequence of vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Identification of viral molecules recognized by influenza-specific human cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

A 15 amino acid fragment of influenza nucleoprotein synthesized in the cytoplasm is presented to class I-restricted cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Anti-viral protection and prevention of lymphocytic choriomeningitis or of the local footpad swelling reaction in mice by immunization with vaccinia-recombinant virus expressing LCMV-WE nucleoprotein or glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

An endogenous processing pathway in vaccinia virus-infected cells for presentation of cytoplasmic antigens to class II-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Interferon gamma is involved in the recovery of athymic nude mice from recombinant vaccinia virus/interleukin 2 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Epitope mapping by deletion mutants and chimeras of two vesicular stomatitis virus glycoprotein genes expressed by a vaccinia virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Immunodeficient mice recover from infection with vaccinia virus expressing interferon-gamma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Mapping and insertional mutagenesis of a vaccinia virus gene encoding a 13,800-Da secreted protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Tumour prevention and rejection with recombinant vaccinia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

High level gene expression in mammalian cells by a nuclear T7-phase RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Vaccinia virus: a selectable eukaryotic cloning and expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Recognition of influenza A virus nucleoprotein by human cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Differences in antigen presentation to MHC class I-and class II-restricted influenza virus-specific cytolytic T lymphocyte clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Regulation of vaccinia virus transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Vaccinia virus expression vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Live recombinant vaccinia virus protects chimpanzees against hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Molecular genetics of vaccinia virus: demonstration of marker rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Vaccinia virus vectors utilizing the beta-galactosidase assay for rapid selection of recombinant viruses and measurement of gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Construction of poxviruses as cloning vectors: insertion of the thymidine kinase gene from herpes simplex virus into the DNA of infectious vaccinia virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Construction of live vaccines by using genetically engineered poxviruses: biological activity of recombinant vaccinia virus expressing influenza virus hemagglutinin

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

A poxvirus-derived vector that directs high levels of expression of cloned genes in mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Cells that express all five proteins of vesicular stomatitis virus from cloned cDNAs support replication, assembly, and budding of defective interfering particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Recombinant vaccinia virus: immunization against multiple pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Vaccinia virus as an expression vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Recovery of immunodeficient mice from a vaccinia virus/IL-2 recombinant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Disseminated vaccinia in a military recruit with human immunodeficiency virus (HIV) disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Genetic engineering of novel genomes of large DNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Response of monkeys to vaccination with recombinant vaccinia virus which coexpress HIV gp160 and human interleukin-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

The lck tyrosine protein kinase interacts with the cytoplasmic tail of the CD4 glycoprotein through its unique amino-terminal domain

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Infectious vaccinia virus recombinants that express hepatitis B virus surface antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Recombinant fowlpox virus inducing protective immunity in non-avian species

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Defective presentation to class I-restricted cytotoxic T lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen.

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Transport to the cell surface of a peptide sequence attached to the truncated C terminus of an N-terminally anchored integral membrane protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Antigen-presenting capacity of epidermal cells infected with vaccinia virus recombinants containing the herpes simplex virus glycoprotein D, and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Mapping of the vaccinia virus thymidine kinase gene by marker rescue and by cell-free translation of selected mRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Class I MHC can present an endogenous peptide to cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Protection from rabies by a vaccinia virus recombinant containing the rabies virus glycoprotein gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Influenza A virus nucleoprotein is a major target antigen for cross-reactive anti-influenza A virus cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

A novel approach for the production of monoclonal antibodies using infectious vaccinia virus recombinants

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Protection of cattle against rinderpest with vaccinia virus recombinants expressing the HA or F gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Oligonucleotide sequence signaling transcriptional termination of vaccinia virus early genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Synthesis of functional mRNA in mammalian cells by bacteriophage T3 RNA polymerase

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Successful vaccination with a polyvalent live vector despite existing immunity to an expressed antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Expression of cystic fibrosis transmembrane conductance regulator corrects defective chloride channel regulation in cystic fibrosis airway epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

Recognition of pre-processed endogenous antigen by class I but not class II MHC-restricted T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

HIV-specific cytotoxic T lymphocytes in seropositive individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1126%2FSCIENCE.2047875

21 January 2018

Identifiers

DOI

10.1126/SCIENCE.2047875

1 reference

22 August 2017

0 references

1 reference

PubMed ID

2047875